What is the initial management of hypovolemic shock?

Initial Management of Hypovolemic Shock

Begin immediate fluid resuscitation with isotonic crystalloids, administering 20 mL/kg boluses rapidly over 5-15 minutes, and repeat as needed based on hemodynamic response while simultaneously identifying and controlling the source of volume loss. 1

Immediate Priorities

1. Rapid Fluid Resuscitation

Crystalloids are the first-line fluid of choice for initial resuscitation in hypovolemic shock 2, 3, 1. The evidence strongly supports:

• Initial bolus: 20-30 mL/kg of isotonic crystalloid administered rapidly (over 5-15 minutes) 1, 4
• Preferred solutions: Balanced crystalloids (Ringer's Lactate) or normal saline 1
• Avoid hypotonic solutions (like Ringer's Lactate in severe head trauma) 3

The 2017 Surviving Sepsis Campaign guidelines recommend at least 30 mL/kg within the first 3 hours for sepsis-induced hypoperfusion 1, and this principle applies broadly to hypovolemic shock. For trauma patients, the 2013 European trauma guidelines specifically recommend crystalloids as initial therapy 3.

2. Vascular Access

• Peripheral IV or intraosseous access is acceptable initially when central access is not immediately available 4
• Obtain access in unburned areas when possible 5
• Do not delay resuscitation to obtain central venous access

3. Reassessment and Repeat Boluses

Continue fluid boluses as long as hemodynamic improvement occurs 1. Monitor:

• Heart rate (decreasing tachycardia)
• Blood pressure (improving MAP toward ≥65 mmHg)
• Capillary refill time (<2 seconds)
• Urine output (≥0.5 mL/kg/hr)
• Mental status (improving consciousness)
• Skin perfusion (warming extremities, reduced mottling) 6
• Lactate levels (trending downward) 7, 1

Hemorrhagic Shock Considerations

For hemorrhagic/traumatic shock, apply damage control resuscitation principles 8:

• Permissive hypotension (target MAP 65 mmHg) until bleeding is controlled 2
• Limit crystalloid volume to avoid dilutional coagulopathy (>2000 mL increases coagulopathy risk significantly) 2
• Early blood product transfusion when massive hemorrhage is evident
• Tranexamic acid should be administered early 9
• Maintain normothermia, pH >7.2, and normocalcemia 9

Critical caveat: Permissive hypotension is contraindicated in traumatic brain injury and spinal cord injury, where adequate cerebral perfusion pressure is essential 2. It should also be used cautiously in elderly patients and those with chronic hypertension 2.

Source Control

Identify and control the source of volume loss as rapidly as possible 1:

• Surgical hemorrhage control
• Endoscopic intervention for GI bleeding
• Pelvic stabilization for pelvic fractures 3
• Removal of infected intravascular devices 1

Monitoring During Resuscitation

Use dynamic assessment rather than static endpoints 1:

• Fluid responsiveness indicators: pulse pressure variation, stroke volume variation (when available)
• Serial lactate measurements to guide resuscitation adequacy 7, 1
• Central venous oxygen saturation (ScvO2) if central access obtained (target ≥70%) 4
• Clinical examination: peripheral perfusion, capillary refill, skin temperature 6

When to Stop or Modify Fluid Resuscitation

Recognize signs of fluid overload and adjust accordingly 10:

• New or worsening pulmonary crackles/rales
• Increasing jugular venous pressure
• Hepatomegaly (especially in pediatric patients) 4
• Lack of hemodynamic improvement despite adequate volume

If fluid overload develops or the patient remains hypotensive despite adequate fluid resuscitation, initiate vasopressor support (norepinephrine first-line, target MAP ≥65 mmHg) rather than continuing aggressive fluid administration 1.

Special Populations

Pediatric patients: Use 20 mL/kg boluses over 5-10 minutes, reassessing after each bolus 4. If hepatomegaly or rales develop, initiate inotropic support rather than additional fluid 4.

Burn patients: Administer 20 mL/kg within the first hour for burns >10-15% TBSA, then follow formula-based resuscitation 5.

Common Pitfalls

• Over-resuscitation with crystalloids leading to dilutional coagulopathy, abdominal compartment syndrome, and pulmonary edema 2
• Delaying source control while focusing solely on fluid resuscitation
• Using colloids or albumin as first-line therapy (no mortality benefit, potentially harmful) 1, 2, 11
• Applying permissive hypotension in head injury patients
• Failing to reassess frequently and continuing fluids despite lack of response